John Paulson’s Madrigal Pharmaceuticals MDGL Stock Holding History

John Paulson’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$720M	Sell	1,340,020 -52,168	-4%	-$26.7M	27.94%	1
2026 Q1	$729M	Sell	1,392,188 -315,334	-18%	-$151M	23.42%	2
2025 Q4	$994M	Sell	1,707,522 -200,001	-10%	-$102M	30.48%	1
2025 Q3	$875M	Sell	1,907,523 -182,000	-9%	-$67.9M	29.46%	1
2025 Q2	$632M	Sell	2,089,523 -10,000	-0.5%	-$2.98M	31.44%	1
2025 Q1	$695M	Buy	2,099,523 +57,523	+3%	+$18.9M	39.81%	1
2024 Q4	$630M	Hold	2,042,000	–	–	38.14%	1
2024 Q3	$393M	Buy	2,042,000 +192,000	+10%	+$49.1M	27.55%	1
2024 Q2	$518M	Buy	1,850,000 +75,000	+4%	+$17.9M	38.31%	1
2024 Q1	$474M	Buy	1,775,000 +669,259	+61%	+$158M	32.74%	1
2023 Q4	$256M	Buy	1,105,741 +605,741	+121%	+$106M	23.09%	1
2023 Q3	$73M	Buy	500,000 +149,800	+43%	+$28.2M	6.53%	6
2023 Q2	$80.9M	Buy	+350,200	New	+$94.9M	7.9%	5

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

John Paulson's MDGL Position: Q2 2026 in Review

John Paulson reduced its Madrigal Pharmaceuticals (MDGL) stake by 3.7% in Q2 2026, selling an estimated $26.7M and leaving 1,340,020 shares worth $720M. The position accounts for 27.94% of the portfolio, ranked #1.

John Paulson first reported a position in MDGL in Q2 2023 and has held it in 13 quarters since. The position peaked at $994M in Q4 2025. 411 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

John Paulson held 1,340,020 shares of Madrigal Pharmaceuticals worth $720M as of Q2 2026.
John Paulson sold 52,168 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $26.7M.
Madrigal Pharmaceuticals made up 27.94% of John Paulson's portfolio in Q2 2026, its #1 holding.
John Paulson first reported a position in Madrigal Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
John Paulson's Madrigal Pharmaceuticals position peaked at $994M in Q4 2025.
411 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Paulson & Co's 13F filing for Q2 2026, filed 14 Aug 2026.